Canada Life’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,380
| Closed | -$13K | – | 2533 |
|
2021
Q3 | $13K | Hold |
1,380
| – | – | ﹤0.01% | 2490 |
|
2021
Q2 | $16K | Hold |
1,380
| – | – | ﹤0.01% | 2515 |
|
2021
Q1 | $14K | Hold |
1,380
| – | – | ﹤0.01% | 2542 |
|
2020
Q4 | $15K | Hold |
1,380
| – | – | ﹤0.01% | 2571 |
|
2020
Q3 | $13K | Hold |
1,380
| – | – | ﹤0.01% | 2504 |
|
2020
Q2 | $11K | Hold |
1,380
| – | – | ﹤0.01% | 2563 |
|
2020
Q1 | $12K | Hold |
1,380
| – | – | ﹤0.01% | 2475 |
|
2019
Q4 | $15K | Hold |
1,380
| – | – | ﹤0.01% | 2553 |
|
2019
Q3 | $15K | Sell |
1,380
-1,220
| -47% | -$13.3K | ﹤0.01% | 1088 |
|
2019
Q2 | $24K | Hold |
2,600
| – | – | ﹤0.01% | 2566 |
|
2019
Q1 | $32K | Hold |
2,600
| – | – | ﹤0.01% | 2324 |
|
2018
Q4 | $30K | Hold |
2,600
| – | – | ﹤0.01% | 2491 |
|
2018
Q3 | $37K | Hold |
2,600
| – | – | ﹤0.01% | 2443 |
|
2018
Q2 | $39K | Hold |
2,600
| – | – | ﹤0.01% | 2452 |
|
2018
Q1 | $34K | Hold |
2,600
| – | – | ﹤0.01% | 2439 |
|
2017
Q4 | $33K | Hold |
2,600
| – | – | ﹤0.01% | 2440 |
|
2017
Q3 | $34K | Hold |
2,600
| – | – | ﹤0.01% | 2415 |
|
2017
Q2 | $38K | Hold |
2,600
| – | – | ﹤0.01% | 2398 |
|
2017
Q1 | $31K | Hold |
2,600
| – | – | ﹤0.01% | 2404 |
|
2016
Q4 | $36K | Sell |
2,600
-5,700
| -69% | -$78.9K | ﹤0.01% | 2395 |
|
2016
Q3 | $111K | Hold |
8,300
| – | – | ﹤0.01% | 2095 |
|
2016
Q2 | $89K | Hold |
8,300
| – | – | ﹤0.01% | 2143 |
|
2016
Q1 | $87K | Hold |
8,300
| – | – | ﹤0.01% | 1881 |
|
2015
Q4 | $98K | Hold |
8,300
| – | – | ﹤0.01% | 1777 |
|
2015
Q3 | $97K | Sell |
8,300
-104
| -1% | -$1.22K | ﹤0.01% | 1726 |
|
2015
Q2 | $122K | Hold |
8,404
| – | – | ﹤0.01% | 1720 |
|
2015
Q1 | $116K | Buy |
8,404
+104
| +1% | +$1.44K | ﹤0.01% | 1705 |
|
2014
Q4 | $114K | Hold |
8,300
| – | – | ﹤0.01% | 1668 |
|
2014
Q3 | $102K | Hold |
8,300
| – | – | ﹤0.01% | 1671 |
|
2014
Q2 | $103K | Buy |
+8,300
| New | +$103K | ﹤0.01% | 1562 |
|